No Data
PKU HealthCare Corp. (000788.SZ): The ownership structure of the controlling Shareholder has been adjusted.
On February 6, Gelonghui reported that PKU HealthCare Corp. (000788.SZ) announced that this adjustment of the Shareholder structure is due to the adjustment of the upper Shareholder structure of the controlling Shareholder of PKU HealthCare Corp. The limited partner of New Advantage International Business Management (Hangzhou) Partnership (Limited Partnership) (referred to as "New Advantage International") has changed from Zhejiang Zhongbei Jiuzhou Group Co., Ltd. (referred to as "Zhongbei Jiuzhou") to Hangzhou Mingman Investment Management Co., Ltd. (referred to as "Hangzhou Mingman"). The executive managing partner of New Advantage International has not changed and remains as Xintong Yanhe Technology (Hainan) Co., Ltd. (referred to as "Xintong Yanhe"). This refers to the controlling Shareholder.
PKU HealthCare Investing 30 Million Yuan to Establish Drug, Food Additive Subsidiary
Peking University Pharmaceuticals: 2024 Annual Results Forecast
The State Council meeting deployed to deepen the regulatory reform of Pharmaceutical and medical instruments, and Institutions indicated that there are significant structural opportunities in the Pharmaceutical Industry.
According to media reports, the recent State Council executive meeting deployed measures to deepen the regulation reform of pharmaceuticals and medical instruments, promoting the high-quality development of the pharmaceutical industry. Orient stated that looking back at 2024, the high base from the past has been digested, and the intra-hospital rigid demand is being released normally. Meanwhile, the Industry Chain of Innovative Drugs and the export of instruments continue to yield results, and the overall growth logic is clearly visible.
The 15% Return Delivered to PKU HealthCareLtd's (SZSE:000788) Shareholders Actually Lagged YoY Earnings Growth
PKU HealthCare Corp. (000788.SZ): Currently, there are no related products for hair growth.
On December 24, Gulonghui reported that PKU HealthCare Corp. (000788.SZ) stated on the investor interaction platform that the company currently has no products related to hair growth. The company mainly engages in the research and development, production, and sales of Chemical Drug formulations as well as pharmaceutical circulation and other businesses. The company's pharmaceutical manufacturing Sector currently focuses on core areas such as anti-infection, analgesics, mental health, and chronic diseases, primarily with generic drugs.
PKU HealthCare Corp.,Ltd.'s (SZSE:000788) 28% Share Price Plunge Could Signal Some Risk
